Skip to main content

Advertisement

SpringerLink
Log in

Comparison of Circulating miRNAs Expression Alterations in Matched Tissue and Plasma Samples During Colorectal Cancer Progression

  • Original Article
  • Published:
Pathology & Oncology Research

Abstract

MicroRNAs (miRNAs) have been found to play a critical role in colorectal adenoma-carcinoma sequence. MiRNA-specific high-throughput arrays became available to detect promising miRNA expression alterations even in biological fluids, such as plasma samples, where miRNAs are stable. The purpose of this study was to identify circulating miRNAs showing altered expression between normal colonic (N), tubular adenoma (ADT), tubulovillous adenoma (ADTV) and colorectal cancer (CRC) matched plasma and tissue samples. Sixteen peripheral plasma and matched tissue biopsy samples (N n = 4; ADT n = 4; ADTV n = 4; CRC n = 4) were selected, and total RNA including miRNA fraction was isolated. MiRNAs from plasma samples were extracted using QIAamp Circulating Nucleic Acid Kit (Qiagen). Matched tissue-plasma miRNA microarray experiments were conducted by GeneChip® miRNA 3.0 Array (Affymetrix). RT-qPCR (microRNA Ready-to-use PCR Human Panel I + II; Exiqon) was used for validation. Characteristic miRNA expression alterations were observed in comparison of AD and CRC groups (miR-149*, miR-3196, miR-4687) in plasma samples. In the N vs. CRC comparison, significant overexpression of miR-612, miR-1296, miR-933, miR-937 and miR-1207 was detected by RT-PCR (p < 0.05). Similar expression pattern of these miRNAs were observed using microarray in tissue pairs, as well. Although miRNAs were also found in circulatory system in a lower concentration compared to tissues, expression patterns slightly overlapped between tissue and plasma samples. Detected circulating miRNA alterations may originate not only from the primer tumor but from other cell types including immune cells.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Fig. 1
Fig. 2
Fig. 3
Fig. 4
Fig. 5
Fig. 6

Similar content being viewed by others

References

  1. Jemal A, Bray F, Center MM, Ferlay J, Ward E, Forman D (2011) Global cancer statistics. CA Cancer J Clin 61(2):69–90. https://doi.org/10.3322/caac.20107

    Article  PubMed  Google Scholar 

  2. Patai AV, Valcz G, Hollosi P, Kalmar A, Peterfia B, Patai A, Wichmann B, Spisak S, Bartak BK, Leiszter K, Toth K, Sipos F, Kovalszky I, Peter Z, Miheller P, Tulassay Z, Molnar B (2015) Comprehensive DNA methylation analysis reveals a common ten-gene methylation signature in colorectal adenomas and carcinomas. PLoS One 10(8):e0133836. https://doi.org/10.1371/journal.pone.0133836

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  3. Yan L, Zhao W, Yu H, Wang Y, Liu Y, Xie C (2016) A comprehensive meta-analysis of MicroRNAs for predicting colorectal cancer. Medicine 95(9):e2738. https://doi.org/10.1097/MD.0000000000002738

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  4. Esquela-Kerscher A, Slack FJ (2006) Oncomirs - microRNAs with a role in cancer. Nat Rev Cancer 6(4):259–269. https://doi.org/10.1038/nrc1840

    Article  CAS  PubMed  Google Scholar 

  5. Nagy ZB, Wichmann B, Kalmar A, Galamb O, Bartak BK, Spisak S, Tulassay Z, Molnar B (2017) Colorectal adenoma and carcinoma specific miRNA profiles in biopsy and their expression in plasma specimens. Clin Epigenetics 9:22. https://doi.org/10.1186/s13148-016-0305-3

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  6. Mitchell PS, Parkin RK, Kroh EM, Fritz BR, Wyman SK, Pogosova-Agadjanyan EL, Peterson A, Noteboom J, O'Briant KC, Allen A, Lin DW, Urban N, Drescher CW, Knudsen BS, Stirewalt DL, Gentleman R, Vessella RL, Nelson PS, Martin DB, Tewari M (2008) Circulating microRNAs as stable blood-based markers for cancer detection. P Natl Acad Sci USA 105(30):10513–10518. https://doi.org/10.1073/pnas.0804549105

    Article  Google Scholar 

  7. Yuan T, Huang X, Woodcock M, Du M, Dittmar R, Wang Y, Tsai S, Kohli M, Boardman L, Patel T, Wang L (2016) Plasma extracellular RNA profiles in healthy and cancer patients. Sci Rep 6:19413. https://doi.org/10.1038/srep19413

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  8. Tufekci KU, Oner MG, Genc S, Genc K (2010) MicroRNAs and multiple sclerosis. Autoimmune Dis 2011:807426. https://doi.org/10.4061/2011/807426

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  9. Ge Q, Shen Y, Tian F, Lu J, Bai Y, Lu Z (2015) Profiling circulating microRNAs in maternal serum and plasma. Mol Med Rep 12(3):3323–3330. https://doi.org/10.3892/mmr.2015.3879

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  10. Leidinger P, Galata V, Backes C, Stahler C, Rheinheimer S, Huwer H, Meese E, Keller A (2015) Longitudinal study on circulating miRNAs in patients after lung cancer resection. Oncotarget 6(18):16674–16685. 10.18632/oncotarget.4322

    Article  PubMed  PubMed Central  Google Scholar 

  11. Ma R, Jiang T, Kang X (2012) Circulating microRNAs in cancer: origin, function and application. J Exp Clin Cancer Res 31:38. https://doi.org/10.1186/1756-9966-31-38

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  12. Pathak S, Meng WJ, Nandy SK, Ping J, Bisgin A, Helmfors L, Waldmann P, Sun XF (2015) Radiation and SN38 treatments modulate the expression of microRNAs, cytokines and chemokines in colon cancer cells in a p53-directed manner. Oncotarget 6(42):44758–44780. https://doi.org/10.18632/oncotarget.5815

    Article  PubMed  PubMed Central  Google Scholar 

  13. Tambyah PA, Sepramaniam S, Mohamed Ali J, Chai SC, Swaminathan P, Armugam A, Jeyaseelan K (2013) microRNAs in circulation are altered in response to influenza a virus infection in humans. PLoS One 8(10):e76811. https://doi.org/10.1371/journal.pone.0076811

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  14. Zhou N, Zhou Y, Tang Y, Yu W (2016) MiR-519 inhibits gastric cancer cell activity through regulation of HuR expression. Journal of Central South University Medical Sciences 41(1):19–23. https://doi.org/10.11817/j.issn.1672-7347.2016.01.003

    Article  CAS  PubMed  Google Scholar 

  15. Sheng L, He P, Yang X, Zhou M, Feng Q (2015) miR-612 negatively regulates colorectal cancer growth and metastasis by targeting AKT2. Cell Death Dis 6:e1808. https://doi.org/10.1038/cddis.2015.184

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  16. Bhajun R, Guyon L, Pitaval A, Sulpice E, Combe S, Obeid P, Haguet V, Ghorbel I, Lajaunie C, Gidrol X (2015) A statistically inferred microRNA network identifies breast cancer target miR-940 as an actin cytoskeleton regulator. Sci Rep 5:8336. https://doi.org/10.1038/Srep08336

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  17. Bobowicz M, Skrzypski M, Czapiewski P, Marczyk M, Maciejewska A, Jankowski M, Szulgo-Paczkowska A, Zegarski W, Pawlowski R, Polanska J, Biernat W, Jaskiewicz J, Jassem J (2016) Prognostic value of 5-microRNA based signature in T2-T3N0 colon cancer. Clin Exp Metastasis 33(8):765–773. https://doi.org/10.1007/s10585-016-9810-1

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  18. Cakmak HA, Coskunpinar E, Ikitimur B, Barman HA, Karadag B, Tiryakioglu NO, Kahraman K, Vural VA (2015) The prognostic value of circulating microRNAs in heart failure: preliminary results from a genome-wide expression study. J Cardiovasc Med 16(6):431–437. https://doi.org/10.2459/JCM.0000000000000233

    Article  CAS  Google Scholar 

  19. Shan X, Wen W, Zhu D, Yan T, Cheng W, Huang Z, Zhang L, Zhang H, Wang T, Zhu W, Zhu Y, Zhu J (2017) miR 1296-5p inhibits the migration and invasion of gastric cancer cells by repressing ERBB2 expression. PLoS One 12(1):e0170298. https://doi.org/10.1371/journal.pone.0170298

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  20. Wei WJ, Wang YL, Li DS, Wang Y, Wang XF, Zhu YX, Pan XD, Wang ZY, Wu Y, Jin L, Wang JC, Ji QH (2015) Association study of single nucleotide polymorphisms in mature microRNAs and the risk of thyroid tumor in a Chinese population. Endocrine 49(2):436–444. https://doi.org/10.1007/s12020-014-0467-8

    Article  CAS  PubMed  Google Scholar 

  21. Dong G, Zhang RF, Xu JJ, Guo YF (2015) Association between microRNA polymorphisms and papillary thyroid cancer susceptibility. Int J Clin Exp Pathol 8(10):13450–13457

    CAS  PubMed  PubMed Central  Google Scholar 

  22. Poliseno L, Haimovic A, Segura MF, Hanniford D, Christos PJ, Darvishian F, Wang J, Shapiro RL, Pavlick AC, Berman RS, Hernando E, Zavadil J, Osman I (2012) Histology-specific microRNA alterations in melanoma. J Invest Dermatol 132(7):1860–1868. https://doi.org/10.1038/jid.2011.451

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  23. Zhang L, Zeng D, Chen Y, Li N, Lv Y, Li Y, Xu X, Xu G (2016) miR-937 contributes to the lung cancer cell proliferation by targeting INPP4B. Life Sci 155:110–115. https://doi.org/10.1016/j.lfs.2016.05.014

    Article  CAS  PubMed  Google Scholar 

  24. Li Y, Liang M, Zhang Z (2014) Regression analysis of combined gene expression regulation in acute myeloid leukemia. PLoS Comput Biol 10(10):e1003908. https://doi.org/10.1371/journal.pcbi.1003908

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  25. Slattery ML, Herrick JS, Mullany LE, Valeri N, Stevens J, Caan BJ, Samowitz W, Wolff RK (2015) An evaluation and replication of miRNAs with disease stage and colorectal cancer-specific mortality. Int J Cancer 137(2):428–438. https://doi.org/10.1002/ijc.29384

    Article  CAS  PubMed  Google Scholar 

  26. Wang W, Sun J, Li F, Li R, Gu Y, Liu C, Yang P, Zhu M, Chen L, Tian W, Zhou H, Mao Y, Zhang L, Jiang J, Wu C, Hua D, Chen W, Lu B, Ju J, Zhang X (2012) A frequent somatic mutation in CD274 3′-UTR leads to protein over-expression in gastric cancer by disrupting miR-570 binding. Hum Mutat 33(3):480–484. https://doi.org/10.1002/humu.22014

    Article  CAS  PubMed  Google Scholar 

  27. Barsotti AM, Beckerman R, Laptenko O, Huppi K, Caplen NJ, Prives C (2012) p53-dependent induction of PVT1 and miR-1204. J Biol Chem 287(4):2509–2519. https://doi.org/10.1074/jbc.M111.322875

    Article  CAS  PubMed  Google Scholar 

  28. Ali Sheikh MS, Xia K, Li F, Deng X, Salma U, Deng H, Wei Wei L, Yang TL, Peng J (2015) Circulating miR-765 and miR-149: potential noninvasive diagnostic biomarkers for geriatric coronary artery disease patients. Biomed Res Int 2015:740301. https://doi.org/10.1155/2015/740301

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  29. Chen YX, Gelfond JAL, McManus LM, Shireman PK (2009) Reproducibility of quantitative RT-PCR array in miRNA expression profiling and comparison with microarray analysis. BMC Genomics 10:407. https://doi.org/10.1186/1471-2164-10-407

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  30. Wang ZS, Zhong M, Bian YH, Mu YF, Qin SL, Yu MH, Qin J (2016) MicroRNA-187 inhibits tumor growth and invasion by directly targeting CD276 in colorectal cancer. Oncotarget 7(28):44266–44276. 10.18632/oncotarget.10023

    Article  PubMed  PubMed Central  Google Scholar 

  31. Tsang WP, Ng EK, Ng SS, Jin H, Yu J, Sung JJ, Kwok TT (2010) Oncofetal H19-derived miR-675 regulates tumor suppressor RB in human colorectal cancer. Carcinogenesis 31(3):350–358. https://doi.org/10.1093/carcin/bgp181

    Article  CAS  PubMed  Google Scholar 

  32. Song Q, Song J, Wang Q, Ma Y, Sun N, Ma J, Chen Q, Xia G, Huo Y, Yang L, Li B (2016) miR-548d-3p/TP53BP2 axis regulates the proliferation and apoptosis of breast cancer cells. Cancer Med 5(2):315–324. https://doi.org/10.1002/cam4.567

    Article  CAS  PubMed  Google Scholar 

  33. Larrea E, Sole C, Manterola L, Goicoechea I, Armesto M, Arestin M, Caffarel MM, Araujo AM, Araiz M, Fernandez-Mercado M, Lawrie CH (2016) New concepts in cancer biomarkers: circulating miRNAs in liquid biopsies. Int J Mol Sci 17(5):627. https://doi.org/10.3390/ijms17050627

    Article  CAS  PubMed Central  Google Scholar 

  34. Ji X, Takahashi R, Hiura Y, Hirokawa G, Fukushima Y, Iwai N (2009) Plasma miR-208 as a biomarker of myocardial injury. Clin Chem 55(11):1944–1949. https://doi.org/10.1373/clinchem.2009.125310

    Article  CAS  PubMed  Google Scholar 

  35. Igaz I, Igaz P (2015) Why is microRNA action tissue specific? A putative defense mechanism against growth disorders, tumor development or progression mediated by circulating microRNA? Med Hypotheses 85(5):530–533. https://doi.org/10.1016/j.mehy.2015.07.013

    Article  CAS  PubMed  Google Scholar 

Download references

Acknowledgments

This study was supported by the National Research, Development and Innovation Office (KMR-12-1-2012-0216 grant) and Hungarian Scientific Research Fund (OTKA-K111743) grant.

Author information

Authors and Affiliations

  1. Molecular Gastroenterology Laboratory, 2nd Department of Internal Medicine, Semmelweis University, Szentkirályi street 46, Budapest, 1088, Hungary

    Zsófia Brigitta Nagy, Barbara Kinga Barták, Alexandra Kalmár, Orsolya Galamb, Barnabás Wichmann, Péter Igaz, Zsolt Tulassay & Béla Molnár

  2. Molecular Medicine Research Group, Hungarian Academy of Sciences, Budapest, Hungary

    Orsolya Galamb, Barnabás Wichmann, Péter Igaz, Zsolt Tulassay & Béla Molnár

  3. Department of Clinical Oncology, Semmelweis University, Budapest, Hungary

    Magdolna Dank

Authors
  1. Zsófia Brigitta Nagy
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Barbara Kinga Barták
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Alexandra Kalmár
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Orsolya Galamb
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. Barnabás Wichmann
    View author publications

    You can also search for this author in PubMed Google Scholar

  6. Magdolna Dank
    View author publications

    You can also search for this author in PubMed Google Scholar

  7. Péter Igaz
    View author publications

    You can also search for this author in PubMed Google Scholar

  8. Zsolt Tulassay
    View author publications

    You can also search for this author in PubMed Google Scholar

  9. Béla Molnár
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Zsófia Brigitta Nagy.

Ethics declarations

All authors read and approved the final manuscript.

Conflict of Interest

The Authors declare that there is no conflict of interest.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Nagy, Z.B., Barták, B.K., Kalmár, A. et al. Comparison of Circulating miRNAs Expression Alterations in Matched Tissue and Plasma Samples During Colorectal Cancer Progression. Pathol. Oncol. Res. 25, 97–105 (2019). https://doi.org/10.1007/s12253-017-0308-1

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s12253-017-0308-1

Keywords

Search

Navigation